<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>. </b><a href="https://link.springer.com/article/10.1007/s40744-017-0070-6">https://link.springer.com/article/10.1007/s40744-017-0070-6</a></p><p></p> <p><br></p> <p><b>Provide enhanced content for this article</b></p> <p><br></p> <p>If you are an author of this publication and would like to provide additional enhanced content for your article then please contact <a href="http://www.medengine.com/Redeem/âmailto:adisrapidplus@springer.comâ"><b>adisrapidplus@springer.com</b></a>.</p> <p><br></p> <p>The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer revi...
Aim: To compare secukinumab with infliximab in biologic-naive patients with psoriatic arthritis usin...
BACKGROUND: Head-to-head trials in psoriatic arthritis are helpful in guiding clinical decision maki...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p></p><p><b>Article full text</b></p> <p><br> </p> <p>The full text of this article can be...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
To access publisher's full text version of this article click on the hyperlink belowObjectives: To c...
Full copyright for enhanced digital features is owned by the authors. Article full text The fu...
Background: Head-to-head trials in psoriatic arthritis are helpful in guiding clinical decision ma...
INTRODUCTION: Secukinumab and adalimumab are approved for adults with active psoriatic arthritis (Ps...
Aim: To compare secukinumab with infliximab in biologic-naive patients with psoriatic arthritis usin...
BACKGROUND: Head-to-head trials in psoriatic arthritis are helpful in guiding clinical decision maki...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p></p><p><b>Article full text</b></p> <p><br> </p> <p>The full text of this article can be...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
To access publisher's full text version of this article click on the hyperlink belowObjectives: To c...
Full copyright for enhanced digital features is owned by the authors. Article full text The fu...
Background: Head-to-head trials in psoriatic arthritis are helpful in guiding clinical decision ma...
INTRODUCTION: Secukinumab and adalimumab are approved for adults with active psoriatic arthritis (Ps...
Aim: To compare secukinumab with infliximab in biologic-naive patients with psoriatic arthritis usin...
BACKGROUND: Head-to-head trials in psoriatic arthritis are helpful in guiding clinical decision maki...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....